127 Host response in patients with ICU-acquired pneumonia ASPIRE-ICU study team The ASPIRE-ICU study team includes Martin Wolkewitz, PhD (Institute of Medical Biometry and Statistics, University Medical Center Freiburg, Freiburg, Germany), Omar Ali, PhD (Microbial Sciences, R&D BioPharmaceuticals, AstraZeneca, Gaithersburg, Maryland), Alexey Ruzin, PhD (Microbial Sciences, R&D BioPharmaceuticals, AstraZeneca, Gaithersburg, Maryland), Leen Timbermont, PhD (University of Antwerp, Antwerp, Belgium), Christine Lammens, BSc (University of Antwerp, Antwerp, Belgium), Sebastiaan Hullegie, MD, PhD (Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht University, Utrecht, Netherlands), Darren Troeman, MD (Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht University, Utrecht, Netherlands), Denise van Hout, MD (Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht University, Utrecht, Netherlands), Daniël Prins, MSc (Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht University, Utrecht, Netherlands), Rubana Kalyani, MSc (Microbial Sciences, R&D BioPharmaceuticals, AstraZeneca, Gaithersburg, Maryland), Mark Eickhoff, MSc (Microbial Sciences, R&D BioPharmaceuticals, AstraZeneca, Gaithersburg, Maryland), Kathryn Shoemaker, MSc (Microbial Sciences, R&D BioPharmaceuticals, AstraZeneca, Gaithersburg, Maryland), Tuba Vilken, PhD (University of Antwerp, Antwerp, Belgium), Jelle Vlaeminck, MSc (University of Antwerp, Antwerp, Belgium), Jasmine Coppens, PhD (University of Antwerp, Antwerp, Belgium), Thomas van der Schalk, MSc (University of Antwerp, Antwerp, Belgium), Basil Britto Xavier, PhD (University of Antwerp, Antwerp, Belgium), Evelina Odisseeva, PhD (Military Medical Academy, Sofia, Bulgaria), Rossitza Vatcheva, PhD (University Hospital Queen Joanna, Sofia, Bulgaria), Michal Drab, MD, PhD (Hospital Kyjov, Kyjov, Czech Republic), Jaromir Vajter,MD, PhD (Motol University Hospital), Kadri Tamme, MD, PhD (Tartu University Hospital, Tartu, Estonia), Muriel Fartoukh, MD, PhD (Hospital Tenon Ap-Hp, Paris, France), Alain LePape,MD, PhD (Lyon Sud Hospital Center, Lyon, France), Mickael Landais, MD, PhD (Centre Hospitalier du Mans, Le Mans, France), Gaetan Plantefève, MD, PhD (Centre Hospitalier Victor Dupouy, Argenteuil, France), Evelina Tacconelli,MD, PhD (Universitätsklinikum Tübingen, Tübingen, Germany), Achim Kaasch,MD, PhD (Institut fü r Medizinische Mikrobiologie und Krankenhaushygiene, Dusseldorf, Germany), Róbert Jurkinya, MD, PhD (Josa Andras Hospital, Ny.regyh.za, Hungary), Iványi Zsolt, MD, PhD (Semmelweis University, Budapest, Hungary), Miranda van Rijen, MD, PhD (Amphia Hospital, Breda, the Netherlands), Olaf Cremer, MD, PhD (University Medical Center Utrecht, Utrecht, the Netherlands), Biljana Carevic, MD (Clinical Center of Serbia, Belgrade, Serbia), Jasna Jevdjić, MD, PhD (Clinical Center Kragujevac, Kragujevac, Serbia), Dolores Escudero, MD, PhD (Hospital Universitario Central de Asturias, Oviedo, Spain), Miguel Sanchez Garcia, MD, PhD (Hospital Clínico San Carlos, Madrid, Spain), Cristina Prat-Aymerich, MD, PhD (Hospital Universitario Germans Trias i Pujol, Badalona, Spain), Borja Suberviola-Cañas, MD, PhD (Hospital Universitario Marqués de Valdecilla, Santander, Spain), Angel Arenzana-Seisdedos MD, (Hospital Universitario Virgen Macarena, Sevilla, Spain), Hü rrem Bodur, MD, PhD (Ankara Numune Training and Research Hospital, Ankara, Turkey), Cenk Kirakli, MD, PhD (Dr Suat Seren Chest Diseases Hospital, Izmir, Turkey), Ilkay Bozkurt, MD, PhD (University Hospital Ondokuz Mayis, Samsun, Turkey), and Sandra Long, MD, PhD (Royal Blackburn Hospital, Blackburn, United Kingdom). 5
RkJQdWJsaXNoZXIy MTk4NDMw